Get access

Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential

Authors

  • Luc Rochette,

    Corresponding author
    • INSERM UMR866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques, Université de Bourgogne, Facultés de Médecine et Pharmacie, Dijon, France
    Search for more papers by this author
  • Stéliana Ghibu,

    1. Department of Pharmacology, Physiology and Physiopathology, Faculty of Pharmacy, University of Medicine and Pharmacy, Cluj-Napoca, Romania
    Search for more papers by this author
  • Carole Richard,

    1. INSERM UMR866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques, Université de Bourgogne, Facultés de Médecine et Pharmacie, Dijon, France
    2. Service des Soins Intensifs de Cardiologie, CHU Bocage, Dijon, France
    Search for more papers by this author
  • Marianne Zeller,

    1. INSERM UMR866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques, Université de Bourgogne, Facultés de Médecine et Pharmacie, Dijon, France
    Search for more papers by this author
  • Yves Cottin,

    1. INSERM UMR866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques, Université de Bourgogne, Facultés de Médecine et Pharmacie, Dijon, France
    2. Service des Soins Intensifs de Cardiologie, CHU Bocage, Dijon, France
    Search for more papers by this author
  • Catherine Vergely

    1. INSERM UMR866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques, Université de Bourgogne, Facultés de Médecine et Pharmacie, Dijon, France
    Search for more papers by this author

Correspondence: Professor Luc Rochette, INSERM UMR866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques, Université de Bourgogne, Facultés de Médecine et Pharmacie, 7 Boulevard Jeanne d'Arc, 21000 Dijon, France

E-mail: luc.rochette@u-bourgogne.fr

Fax: +33-380-393-293

Abstract

Diabetes has emerged as a major threat to worldwide health. The exact mechanisms underlying the disease are unknown; however, there is growing evidence that the excess generation of reactive oxygen species (ROS) associated with hyperglycemia, causes oxidative stress in a variety of tissues. In this context, various natural compounds with pleiotropic actions like α-lipoic acid (LA) are of interest, especially in metabolic diseases such as diabetes. LA, either as a dietary supplement or a therapeutic agent, modulates redox potential because of its ability to match the redox status between different subcellular compartments as well as extracellularly. Both the oxidized (disulfide) and reduced (di-thiol: dihydro-lipoic acid, DHLA) forms of LA show antioxidant properties. LA exerts antioxidant effects in biological systems through ROS quenching but also via an action on transition metal chelation. Dietary supplementation with LA has been successfully employed in a variety of in vivo models of disease associated with an imbalance of redox status: diabetes and cardiovascular diseases. The complex and intimate association between increased oxidative stress and increased inflammation in related disorders such as diabetes, makes it difficult to establish the temporal sequence of the relationship.

Ancillary